WNT4 rs7521902: Endometriosis Risk & Reproductive Biology
The rs7521902 polymorphism is an intergenic single nucleotide polymorphism situated on chromosome 1 near the WNT4 gene. In genome-wide association studies, this variant has been investigated for modest statistical associations with gynecological traits, specifically advanced-stage endometriosis and reproductive tract biology. Carrying specific alleles confers a slight statistical variation in risk across certain populations rather than directly causing disease.
What each genotype means
| Genotype | What the research suggests | Reading |
|---|---|---|
| AA | Carries two copies of the ancestral A allele. In published genome-wide association studies, this baseline genotype is not associated with elevated relative risk for advanced endometriosis compared to minor allele carriers. It represents a common and standard genotype across global populations. | Informational |
| AC | Carries one copy of the A allele and one copy of the C allele. In certain population cohorts, carrying the C allele has shown modest statistical associations with susceptibility to stage III/IV endometriosis, though the overall effect size is subtle. It is considered a benign and common heterozygous carrier state. | Informational |
| CC | Carries two copies of the minor C allele. Cohort studies have reported a slight relative increase in statistical susceptibility to advanced endometriosis, though absolute risk remains low and heavily influenced by non-genetic factors. This genotype is not diagnostic and carries limited clinical predictive power. | Higher attention |
Genomic Location and Variant Characteristics
The single nucleotide polymorphism designated rs7521902 resides on the short arm of chromosome 1 at position 1p36.12. It represents an intergenic transition between adenine (A) and cytosine (C), located in non-coding DNA upstream of the WNT4 protein-coding sequence. Because it does not directly alter the amino acid sequence of any cellular protein, researchers classify rs7521902 as a putative regulatory variant or a tagging marker in linkage disequilibrium with other functional non-coding elements. Large genomic mapping studies suggest that non-coding variations in this region of 1p36 can influence the transcriptional activity or enhancer binding profiles of nearby loci, including WNT4, CDC42, and long non-coding RNAs such as LINC00339. As an intergenic marker, rs7521902 primarily serves in association studies to pinpoint genomic intervals linked with female reproductive development and pelvic organ remodeling.
The Biological Role of the WNT4 Gene
The WNT4 gene encodes Wnt Family Member 4, a secreted signaling glycoprotein belonging to the evolutionarily conserved Wnt family. WNT4 signaling is essential during embryogenesis for the establishment and specialization of the female reproductive system. It directs the normal development of the Müllerian ducts, which ultimately differentiate into the fallopian tubes, uterus, cervix, and upper vaginal canal. In postnatal life, WNT4 continues to play a central role in regulating ovarian follicle maturation, steroidogenesis, and the cyclic remodeling and decidualization of the human endometrial lining. Disruption or differential regulation of Wnt signaling cascades in endometrial stroma has been implicated in altered tissue growth, cell migration, and structural phenotypes that characterize peritoneal and pelvic gynecological disorders.
Research Associations and Evidence Strength
Initial genome-wide association studies (GWAS) identified rs7521902 as a candidate risk marker for moderate to severe (stages III and IV) endometriosis. However, the evidence supporting rs7521902 as an independent causal driver remains limited and mixed. While systematic reviews and meta-analyses, such as those synthesized by Meidyana and colleagues, have noted collective associations between WNT4 locus markers and endometriosis risk across multiple cohorts, standalone replication attempts in distinct cohorts have yielded inconsistent results. Fine-mapping efforts on chromosome 1p36 indicate that other nearby variants, such as rs16826658 and rs3820282, may exert stronger regulatory effects or account more directly for the local statistical signal. Consequently, rs7521902 is considered a modest susceptibility marker reflecting regional genetic architecture rather than a definitive causal variant.
Population Frequency and Diversity
The distribution of rs7521902 alleles exhibits meaningful variation across global ancestral groups. In European populations, the minor allele (C) is relatively common, with an observed frequency of roughly 33% (0.33). Because the minor allele is widespread in healthy cohorts, carrying one or two copies is a standard human variation rather than a rare anomaly. In East Asian and other non-European populations, allele frequencies and linkage patterns on chromosome 1p36 can differ substantially. These differences in linkage disequilibrium mean that an association found in one population may not replicate cleanly in another, highlighting why genomic risk estimates derived primarily from specific cohorts cannot be universally generalized without careful multi-ancestry validation.
Clinical Utility and Consumer Considerations
Information regarding an individual's rs7521902 genotype is strictly educational and cannot be used to diagnose, rule out, or monitor endometriosis or any other medical condition. Endometriosis is a complex, multifactorial disorder influenced by a wide array of polygenic factors, hormonal influences, immune mechanisms, and environmental exposures. Having a statistically associated genotype does not mean an individual will develop pelvic pain, lesions, or subfertility; conversely, lacking the risk allele provides no guarantee against developing gynecological conditions. Individuals experiencing chronic pelvic pain, severe dysmenorrhea, or fertility challenges should not rely on direct-to-consumer genetic markers, but should instead consult a licensed obstetrician-gynecologist or reproductive specialist for proper clinical evaluation and evidence-based care.
How common is this variant?
The minor C allele occurs at a frequency of approximately 0.33 in European cohorts, making heterozygous and homozygous genotypes widespread among healthy individuals across global population databases.
Frequently asked questions
Can the rs7521902 test diagnose endometriosis?
No. Genetic testing for rs7521902 cannot diagnose or rule out endometriosis. Endometriosis is a complex disorder requiring clinical evaluation, imaging, or laparoscopic visualization by a physician for a definitive diagnosis.
Does having the CC genotype mean I will develop pelvic pain or infertility?
Not at all. The CC genotype is associated only with a small statistical shift in relative risk observed in large population studies. The majority of individuals with this common genotype never develop endometriosis or related reproductive complications.
Why is research evidence on rs7521902 considered limited?
While initial GWAS identified rs7521902, subsequent replication studies across diverse ethnic groups produced mixed results. Furthermore, fine-mapping studies suggest that neighboring polymorphisms on chromosome 1p36 may carry stronger biological effects on WNT4 regulation.
What should I do if I have symptoms of endometriosis?
If you experience symptoms such as severe menstrual cramps, deep pelvic pain, or difficulty conceiving, discuss these concerns directly with a qualified gynecologist. Clinical management depends on physical evaluations and symptoms rather than commercial genetic test results.
Sources & further reading
Educational information only, last refreshed 9/11/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs7521902?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29